Raschi, E <br/><br/>
Reduced reporting of neuropsychiatric adverse events with tumor necrosis factor alpha inhibitors for hidradenitis suppurativa: caution before concluding for risk reduction.  [electronic resource] 

 -  Journal of the European Academy of Dermatology and Venereology : JEADV  Aug 2020 
 - e430-e431 p.  digital 
<br/><br/> Publication Type: Letter 
<br/><br/><label>ISSN: </label>1468-3083 
<br/><br/><label>Standard No.: </label>10.1111/jdv.16379  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adalimumab<br/>Hidradenitis Suppurativa--drug therapy<br/>Humans<br/>Immunologic Factors<br/>Risk Reduction Behavior<br/>Tumor Necrosis Factor-alpha